Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine versus cetirizine for cutaneous pruritus
ChiCTR-TRC-11001485Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pruritus comparing Olopatadine group with Cetirizine group (2 arms). Primary endpoint: Symptom score reducing index. Started Aug 2007; status: completed.
02
Drugs
olopatadinecetirizine
03
Conditions
pruritus
Beyond the preview
Go deeper on ChiCTR-TRC-11001485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001485.